The average American spends more than 90% of their time indoors, breathing air that is potentially bad for their health. In fact, the EPA estimates that concentrations of some pollutants in an indoor environment are often 2-5 times higher – even up to 100 times higher – than outdoor concentrations.

Many indoor pollutants are odorless, colorless, and invisible to the naked eye making them difficult to identify and remedy. As a result, they are often overlooked as potential triggers behind a wide range of health conditions.


The EPA found that nearly 50% of buildings were experiencing ongoing problems with leaks causing water damage. In reality, this number is likely to be much higher. The unfortunate truth is that where there is moisture, there is the opportunity for mold and other microbial growth.

While there are a number of indoor pollutants that can make us sick, living and working in mold and water-damaged homes and buildings has been shown to affect us from conception to grave.

To learn more, click through our interactive “Conception to Grave” slideshow.


Due to an epidemic of water damage, toxin-producing molds have taken up residence in the majority of our homes, schools, municipal and commercial buildings.  Exposure to contaminates from water-damaged building materials and contents presents a serious health risk from…

"Conception to Grave”


Related Conditions – Infertility;
Fetal Mycotoxin Exposure; Miscarriage

Though not currently tracked as a risk factor by the CDC, exposure to mold toxins has been shown to affect fertility in both animals and humans.

It is estimated that one in four pregnancies in the U.S. currently results in miscarriage. Indoor air pollution, including mycotoxins, is consistently overlooked and not communicated as a risk factor.

It’s well-known that animals that consume moldy food can end up with mold toxins in their milk, eggs, and meat. The same holds true for expectant mothers living in water damaged homes with toxic mold.


Related Conditions – Low Birth Weight; Birth Defects; Spina Bifida; Autism; Childhood Cancers

Exposure to molds, mycotoxins, and other contaminates in water-damaged buildings increases the risk of low birth weight and birth defects, such as spina bifida.

Children with autism have been shown to have problems with detoxification, making them particularly susceptible to negative health effects from exposure to toxins - and should be protected from any such exposure.

Billions of donor dollars are spent each year trying to “cure” childhood cancer. Yet, we’re failing to study the major impact IAQ, mold, and carcinogenic mycotoxins have on cancer risk.


Related Conditions – PANS/PANDAS; Attention Deficit Disorder; Asthma; Sinus Infections

Exposure to mold and mycotoxins presents a significant risk of several childhood developmental disorders, including PANS/PANDAS, ADHD, and anxiety.

Numerous studies have shown mold exposure significantly increases asthma risk. Investigating and remediating water damage is essential to managing this serious, costly condition.

Studies have repeatedly shown exposure to water damaged environments significantly increases risk of sinusitis and rhinitis. In one study of chronic sinus infection, 93% were cases of allergic fungal sinusitis. Reducing mold exposure reduces sinusitis symptoms.


Related Conditions – Premature Puberty;
ME/CFS (Chronic Fatigue Syndrome)

Indoor exposure to the mycotoxin zearalenone - a chemical mimic of the hormone estrogen - has been linked to premature puberty.

Exposure to water damaged environments increases the risk of chronic, post-infectious, inflammatory diseases, like ME/CFS. One study showed as many as 90% of cases of ME/CFS were associated with mold exposure.

With the onset of Long COVID the population meeting the criteria for ME/CFS has more than quadrupled to an estimated 9M Americans. Current estimates of the annual economic impact now results in $149 to $362 billion in medical expenses and lost income.

The CDC states that about 90% of people with ME/CFS have NOT been diagnosed, due to limited access to healthcare, and a lack of education among healthcare providers. Simple math shows the impacts of mold-related ME/CFS and Long-COVID - could be in the TRILLIONS of dollars annually.


Related Conditions – Chronic Inflammatory Response Syndrome (CIRS); Anxiety; Depression; Inflammatory GI Diseases (IBD, Crohn’s)

Adults, young and old, need to be keenly aware of the health risks posed by water damage, mold and mycotoxins. Be on the lookout for changes in symptoms with a change in environment. This often manifests as a condition called CIRS - a complex, multisystem, multi-symptom, inflammatory illness.

Indoor air quality has significant potential to impact our mental health. Exposure to mold has been proven to cause changes in behavior and cognitive function, leading to anxiety, depression, and problems with memory and mental processing. Living in a home with moderate mold contamination, increased risk of depression by 34-44%.

Mycotoxins damage our gut lining – leading to leaky gut, food sensitivities, and inflammatory gastrointestinal diseases, such as IBD, ulcerative colitis, and Crohn’s disease. Exposure to mycotoxins has been shown to reduce the diversity in our microbiome, disrupting our metabolism and allowing opportunistic pathogens to thrive.


Related Conditions – Multiple Sclerosis;
Chronic Kidney Disease; COVID-19; Cancers

Compelling evidence links MS to a combination of fungal infection and damage from associated toxins. Any abnormal neurological symptoms – numbness, tingling, body temperature dysregulation, dizziness, brain fog – may indicate exposure to toxigenic mold.

Several toxins produced by molds are known to be toxic to the kidneys. The risks of indoor and food-borne mold and mycotoxins – is a problem plainly visible in our pets, as well.

Some mold toxins are known to suppress the immune system. MPA, a chemical produced by a mold found in nearly 9 out of 10 US homes, is a pharmaceutical-grade immune suppressant. Clearly, this sort of exposure should be considered as a risk factor for serious infectious illnesses such as COVID-19.

Some common indoor mold toxins are known or are suspected to be human carcinogens. However, we do not currently track indoor air quality, mold, and mycotoxins in our cancer risk factors.


Related Conditions – Alzheimer’s; Parkinson’s Disease; ALS

Many seniors have been living in the same home for decades. The ever-increasing maintenance burden leads inevitably to significant chronic water damage, posing an extremely high risk of mold and mycotoxin exposure.

One of the primary forms of Alzheimer’s disease has been linked to inhalational exposure to toxins, such as mold toxins. Addressing this one underlying cause could prevent a significant portion of the population from ever having to suffer.

Parkinson’s disease is primarily a neuro-inflammatory condition. Many toxins produced by indoor molds are known to be neurotoxic and inflammatory. It has also been shown that the gut biomes of Parkinson’s patients are significantly altered.

There is strong evidence connecting fungal sinus infection and exposure to resulting mold toxins to the development of ALS.


Related Conditions – Fungal Infection; Cancers; COVID-19; Alzheimer’s;
Chronic Liver/Kidney Disease

Between 2001 and 2020, seven infants died from Aspergillus fungal infections, acquired at a single hospital in the Pacific Northwest with a long history of water damage.

Aflatoxin - a mycotoxin made by a mold found in an estimated 50% of U.S. homes, is a known liver carcinogen. The CDC’s page on Aflatoxin and cancer risk speaks only of food-borne exposure – and nothing of indoor, inhalational exposure. Given our water damaged building statistics, this is clearly a significant risk.

There are credible associations between mold and mycotoxin exposure and 6 of the CDC’s 10 leading causes of death, as of 2021, including: cancer, COVID-19, chronic lower respiratory disease, Alzheimer’s disease, chronic liver disease, and kidney disease. However, we still lack effective research into these connections.

previous arrowprevious arrow
next arrownext arrow
previous arrow
next arrow

This is NOT an exhaustive list, and some conditions – like cancers and ME/CFS – can strike at most any stage of life.
New research  is regularly uncovering new connections between IAQ, mold, mycotoxins, and our health.

Download a PDF version of "Conception to Grave" here.


Stephen Vesper , Larry Wymer , David Cox , Gary Dewalt , Eugene Pinzer , Warren Friedman & Peter J. Ashley (2021) The Environmental Relative Moldiness Index reveals changes in mold contamination in United States homes over time, Journal of Occupational and Environmental Hygiene, 18:1, 35-41, DOI: 10.1080/15459624.2020.1844892

 Kristian Fog Nielsen, Mycotoxin production by indoor molds, Fungal Genetics and Biology, Volume 39, Issue 2, 2003, Pages 103-117, ISSN 1087-1845, (

 Sharma RP. Immunotoxicity of mycotoxins. J Dairy Sci. 1993 Mar;76(3):892-7. doi: 10.3168/jds.S0022-0302(93)77415-9. PMID: 8463496.

König S, Pace S, Pein H, Heinekamp T, Kramer J, Romp E, Straßburger M, Troisi F, Proschak A, Dworschak J, Scherlach K, Rossi A, Sautebin L, Haeggström JZ, Hertweck C, Brakhage AA, Gerstmeier J, Proschak E, Werz O. Gliotoxin from Aspergillus fumigatus Abrogates Leukotriene B4 Formation through Inhibition of Leukotriene A4 Hydrolase. Cell Chem Biol. 2019 Apr 18;26(4):524-534.e5. doi: 10.1016/j.chembiol.2019.01.001. Epub 2019 Feb 7. PMID: 30745237.

Bondy GS, Pestka JJ. Immunomodulation by fungal toxins. J Toxicol Environ Health B Crit Rev. 2000 Apr-Jun;3(2):109-43. doi: 10.1080/109374000281113. PMID: 10834078.

Heischmann S, Dzieciatkowska M, Hansen K, Leibfritz D, Christians U. The Immunosuppressant Mycophenolic Acid Alters Nucleotide and Lipid Metabolism in an Intestinal Cell Model. Sci Rep. 2017 Mar 22;7:45088. doi: 10.1038/srep45088. PMID: 28327659; PMCID: PMC5361167.

 National Research Council. 1983. Protection Against Trichothecene Mycotoxins. Washington, DC: The National Academies Press.

 Guerre P. Mycotoxin and Gut Microbiota Interactions. Toxins (Basel). 2020 Dec 4;12(12):769. doi: 10.3390/toxins12120769. PMID: 33291716; PMCID: PMC7761905.

Boonen J, Malysheva SV, Taevernier L, Diana Di Mavungu J, De Saeger S, De Spiegeleer B. Human skin penetration of selected model mycotoxins. Toxicology. 2012 Nov 15;301(1-3):21-32. doi: 10.1016/j.tox.2012.06.012. Epub 2012 Jun 27. PMID: 22749975.

 Mukherjee, P., Roy, S., Ghosh, D. et al. Role of animal models in biomedical research: a review. Lab Anim Res 38, 18 (2022).

 Eze, Ukpai & Lewis, Sheena & Connolly, Lisa & Gong, Yun Yun. (2015). ‘Mycotoxins as potential cause of human infertility’ – Evidence from animal and cell models.

Dugas C, Slane VH. Miscarriage. [Updated 2022 Jun 27]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan-. Available from:

 İlknur Münevver Gönenç, Neslihan Yilmaz Sezer & Serkan Yilmaz (2020) Mycotoxin exposure and pregnancy, Critical Reviews in Toxicology, 50:7, 594-604, DOI: 10.1080/10408444.2020.1803791

Thrasher JD, Gray MR, Kilburn KH, Dennis DP, Yu A. A water-damaged home and health of occupants: a case study. J Environ Public Health. 2012;2012:312836. doi: 10.1155/2012/312836. Epub 2011 Dec 15. PMID: 22220187; PMCID: PMC3246741.

Alvito P, Pereira-da-Silva L. Mycotoxin Exposure during the First 1000 Days of Life and Its Impact on Children's Health: A Clinical Overview. Toxins (Basel). 2022 Mar 4;14(3):189. doi: 10.3390/toxins14030189. PMID: 35324686; PMCID: PMC8955462.

 A. WALLACE HAYES, MYCOTOXIN TERATOGENICITY, Editor(s): PHILIP ROSENBERG, Toxins, Pergamon, 1978, Pages 739-758, ISBN 9780080226408, (

Gelineau-van Waes J, Voss KA, Stevens VL, Speer MC, Riley RT. Maternal fumonisin exposure as a risk factor for neural tube defects. Adv Food Nutr Res. 2009;56:145-81. doi: 10.1016/S1043-4526(08)00605-0. PMID: 19389609.

Marasas WFO, Riley PT, Hendricks KA, Stevens VL, Sadler TW, et al. 2002. Fumonisins disrupt sphingolipid metabolism, folate transport, and neural tube development in embryo culture and in vivo: A potential risk factor for human neural tube defects among populations consuming fumonisin-contaminated maize. J Nutr 134:711-6.

Mengxiang Zhang et al., A quasi-paired cohort strategy reveals the impaired detoxifying function of microbes in the gut of autistic children. Sci. Adv.6,eaba3760(2020).DOI:10.1126/sciadv.aba3760

 ALSAC/St. Jude Children’s Research Hospital. “ALSAC/St. Jude 2021 Annual Report”. 2023,

 Centers for Disease Control and Prevention.  “Risk Factors and Cancer.” Centers for Disease Control and Prevention, 20 June 2023,

 Ezra N, Dang K, Heuser G. Improvement of attention span and reaction time with hyperbaric oxygen treatment in patients with toxic injury due to mold exposure. Eur J Clin Microbiol Infect Dis. 2011 Jan;30(1):1-6. doi: 10.1007/s10096-010-0937-8. Epub 2010 Oct 27. PMID: 20978814; PMCID: PMC2998645.

Empting LD. Neurologic and neuropsychiatric syndrome features of mold and mycotoxin exposure. Toxicol Ind Health. 2009 Oct-Nov;25(9-10):577-81. doi: 10.1177/0748233709348393. PMID: 19854819.

 Indoor mould exposure, asthma and rhinitis: findings from systematic reviews and recent longitudinal studies. Denis Caillaud, Benedicte Leynaert, Marion Keirsbulck, Rachel Nadif. European Respiratory Review Jun 2018, 27 (148) 170137; DOI: 10.1183/16000617.0137-2017

Empting LD. Neurologic and neuropsychiatric syndrome features of mold and mycotoxin exposure. Toxicol Ind Health. 2009 Oct-Nov;25(9-10):577-81. doi: 10.1177/0748233709348393. PMID: 19854819.

Curtis L. Reducing Fungal Exposure Critical for Treating Rhinosinusitis with or without Polyps [Letter]. J Asthma Allergy. 2021 Mar 24;14:275-276. doi: 10.2147/JAA.S311060. PMID: 33790582; PMCID: PMC8005363.

 Ponikau JU, Sherris DA, Kern EB, Homburger HA, Frigas E, Gaffey TA, Roberts GD. The diagnosis and incidence of allergic fungal sinusitis. Mayo Clin Proc. 1999 Sep;74(9):877-84. doi: 10.4065/74.9.877. PMID: 10488788.

Massart F, Meucci V, Saggese G, Soldani G. High growth rate of girls with precocious puberty exposed to estrogenic mycotoxins. J Pediatr. 2008 May;152(5):690-5, 695.e1. doi: 10.1016/j.jpeds.2007.10.020. Epub 2008 Feb 20. PMID: 18410776.

 Massart F, Saggese G. Oestrogenic mycotoxin exposures and precocious pubertal development. Int J Androl. 2010 Apr;33(2):369-76. doi: 10.1111/j.1365-2605.2009.01009.x. Epub 2009 Nov 30. PMID: 20002219.

 Wu TY, Khorramshahi T, Taylor LA, Bansal NS, Rodriguez B, Rey IR. Prevalence of Aspergillus-Derived Mycotoxins (Ochratoxin, Aflatoxin, and Gliotoxin) and Their Distribution in the Urinalysis of ME/CFS Patients. Int J Environ Res Public Health. 2022 Feb 12;19(4):2052. doi: 10.3390/ijerph19042052. PMID: 35206241; PMCID: PMC8872248.

 Brewer JH, Thrasher JD, Straus DC, Madison RA, Hooper D. Detection of mycotoxins in patients with chronic fatigue syndrome. Toxins (Basel). 2013 Apr 11;5(4):605-17. doi: 10.3390/toxins5040605. PMID: 23580077; PMCID: PMC3705282.

Committee on the Diagnostic Criteria for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome; Board on the Health of Select Populations; Institute of Medicine. Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Redefining an Illness. Washington (DC): National Academies Press (US); 2015 Feb 10. PMID: 25695122.

 Arthur A. Mirin, Mary E. Dimmock & Leonard A. Jason (2022) Updated ME/CFS prevalence estimates reflecting post-COVID increases and associated economic costs and funding implications, Fatigue: Biomedicine, Health & Behavior, 10:2, 83-93, DOI: 10.1080/21641846.2022.2062169

Centers for Disease Control and Prevention.  “Myalgic Encephalomyelitis/Chronic Fatigue Syndrome – What is ME/CFS?.” Centers for Disease Control and Prevention, 21 March 2023,

 Diagnostic Process for Chronic Inflammatory Response Syndrome (CIRS): A Consensus Statement Report of the Consensus Committee of Surviving Mold, Shoemaker, R., Johnson, K., Lysander, J., Berry, Y.,  Dooley, M.,  Ryan, J., McMahon, S., Internal Medicine Review, 2018, Accessed 16 June 2023, (

Gordon WA, Cantor JB, Johanning E, Charatz HJ, Ashman TA, Breeze JL, Haddad L, Abramowitz S. Cognitive impairment associated with toxigenic fungal exposure: a replication and extension of previous findings. Appl Neuropsychol. 2004;11(2):65-74. doi: 10.1207/s15324826an1102_1. PMID: 15477176.

Empting L. Neurologic and neuropsychiatric syndrome features of mold and mycotoxin exposure. Toxicology and Industrial Health. 2009;25(9-10):577-581. doi:10.1177/0748233709348393

 Rea WJ, Didriksen N, Simon TR, Pan Y, Fenyves EJ, Griffiths B. Effects of toxic exposure to molds and mycotoxins in building-related illnesses. Arch Environ Health. 2003 Jul;58(7):399-405. doi: 10.1080/00039896.2003.11879140. PMID: 15143852.

Cheryl F. Harding, Carolyn L. Pytte, Kimberly G. Page, Kelly J. Ryberg, Edna Normand, Gregory J. Remigio, Richard A. DeStefano, David B. Morris, Julia Voronina, Ariel Lopez, Lauren A. Stalbow, Erin P. Williams, Nohely Abreu. Mold inhalation causes innate immune activation, neural, cognitive and emotional dysfunction, Brain, Behavior, and Immunity, Volume 87, 2020, Pages 218-228, ISSN 0889-1591. (

 Potera C. Molding a link to depression. Environ Health Perspect. 2007 Nov;115(11):A536. doi: 10.1289/ehp.115-a536a. PMID: 18007972; PMCID: PMC2072855.

Gao Y, Meng L, Liu H, Wang J, Zheng N. The Compromised Intestinal Barrier Induced by Mycotoxins. Toxins (Basel). 2020 Sep 28;12(10):619. doi: 10.3390/toxins12100619. PMID: 32998222; PMCID: PMC7600953.

Alassane-Kpembi I, Pinton P, Oswald IP. Effects of Mycotoxins on the Intestine. Toxins (Basel). 2019 Mar 13;11(3):159. doi: 10.3390/toxins11030159. PMID: 30871167; PMCID: PMC6468410.

Liew WP, Mohd-Redzwan S. Mycotoxin: Its Impact on Gut Health and Microbiota. Front Cell Infect Microbiol. 2018 Feb 26;8:60. doi: 10.3389/fcimb.2018.00060. PMID: 29535978; PMCID: PMC5834427.

Gonkowski S, Gajęcka M, Makowska K. Mycotoxins and the Enteric Nervous System. Toxins (Basel). 2020 Jul 19;12(7):461. doi: 10.3390/toxins12070461. PMID: 32707706; PMCID: PMC7404981.

 Purzycki CB, Shain DH. Fungal toxins and multiple sclerosis: a compelling connection. Brain Res Bull. 2010 Apr 29;82(1-2):4-6. doi: 10.1016/j.brainresbull.2010.02.012. Epub 2010 Mar 7. PMID: 20214953.

Benito-León J, Laurence M. The Role of Fungi in the Etiology of Multiple Sclerosis. Front Neurol. 2017 Oct 16;8:535. doi: 10.3389/fneur.2017.00535. PMID: 29085329; PMCID: PMC5650687.

 Omotayo OP, Omotayo AO, Mwanza M, Babalola OO. Prevalence of Mycotoxins and Their Consequences on Human Health. Toxicol Res. 2019 Jan;35(1):1-7. doi: 10.5487/TR.2019.35.1.001. Epub 2018 Jan 15. PMID: 30766652; PMCID: PMC6354945.

 Haonan Ruan, Qian Lu, Jiashuo Wu, Jiaan Qin, Ming Sui, Xinqi Sun, Yue Shi, Jiaoyang Luo & Meihua Yang (2022) Hepatotoxicity of food-borne mycotoxins: molecular mechanism, anti-hepatotoxic medicines and target prediction, Critical Reviews in Food Science and Nutrition, 62:9, 2281-2308, DOI: 10.1080/10408398.2021.1960794

 Ráduly Z, Price RG, Dockrell MEC, Csernoch L, Pócsi I. Urinary Biomarkers of Mycotoxin Induced Nephrotoxicity-Current Status and Expected Future Trends. Toxins (Basel). 2021 Nov 28;13(12):848. doi: 10.3390/toxins13120848. PMID: 34941686; PMCID: PMC8708607.

 Hope JH, Hope BE. A review of the diagnosis and treatment of Ochratoxin A inhalational exposure associated with human illness and kidney disease including focal segmental glomerulosclerosis. J Environ Public Health. 2012;2012:835059. doi: 10.1155/2012/835059. Epub 2011 Dec 29. PMID: 22253638; PMCID: PMC3255309.

 Pierron A, Alassane-Kpembi I, Oswald IP. Impact of mycotoxin on immune response and consequences for pig health. Anim Nutr. 2016 Jun;2(2):63-68. doi: 10.1016/j.aninu.2016.03.001. Epub 2016 Mar 23. PMID: 29767037; PMCID: PMC5941016.

 Abd Rahman AN, Tett SE, Staatz CE. Clinical pharmacokinetics and pharmacodynamics of mycophenolate in patients with autoimmune disease. Clin Pharmacokinet. 2013 May;52(5):303-31. doi: 10.1007/s40262-013-0039-8. PMID: 23475567.

 Ahmed Adam MA, Tabana YM, Musa KB, Sandai DA. Effects of different mycotoxins on humans, cell genome and their involvement in cancer (Review). Oncol Rep. 2017 Mar;37(3):1321-1336. doi: 10.3892/or.2017.5424. Epub 2017 Feb 6. PMID: 28184933.

National Institute of Health.  “Aflatoxins.” National Cancer Institute – Cancer Causing Substances, 5 December 2022,

Healthy People 2030, U.S. Department of Health and Human Services, Office of Disease Prevention and Health Promotion. Retrieved [2 July 2023], from

 Rao RV, Subramaniam KG, Gregory J, Bredesen AL, Coward C, Okada S, Kelly L, Bredesen DE. Rationale for a Multi-Factorial Approach for the Reversal of Cognitive Decline in Alzheimer's Disease and MCI: A Review. Int J Mol Sci. 2023 Jan 14;24(2):1659. doi: 10.3390/ijms24021659. PMID: 36675177; PMCID: PMC9865291.

Bredesen DE. Inhalational Alzheimer's disease: an unrecognized - and treatable - epidemic. Aging (Albany NY). 2016 Feb;8(2):304-13. doi: 10.18632/aging.100896. PMID: 26870879; PMCID: PMC4789584

Alonso R, Pisa D, Aguado B, Carrasco L. Identification of Fungal Species in Brain Tissue from Alzheimer's Disease by Next-Generation Sequencing. J Alzheimers Dis. 2017;58(1):55-67. doi: 10.3233/JAD-170058. PMID: 28387676.

Alonso R, Pisa D, Marina AI, Morato E, Rábano A, Carrasco L. Fungal infection in patients with Alzheimer's disease. J Alzheimers Dis. 2014;41(1):301-11. doi: 10.3233/JAD-132681. PMID: 24614898.

 Reid WK. Mycotoxins causing amyotrophic lateral sclerosis. Med Hypotheses. 2021 Apr;149:110541. doi: 10.1016/j.mehy.2021.110541. Epub 2021 Feb 15. PMID: 33631494.